{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T22:05:41Z","timestamp":1769033141218,"version":"3.49.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Systemic lupus erythematosus (SLE) is a systemic autoimmune disorder characterized by inflammatory damage to multiple organs. Its incidence rate is relatively high among women of childbearing age. The use of biologics is not recommended during pregnancy in SLE patients; belimumab or rituximab may be considered selectively only during lactation. Telitacicept is a fusion protein composed of the extracellular domain of the transmembrane activator and CAML interactor (TACI)\u2014a receptor for B-lymphocyte stimulator (BLyS)\u2014and the Fc fragment of human IgG1. It was first approved in China in 2021 for the treatment of patients with active SLE. Currently, there is a lack of safety data on the use of telitacicept during pregnancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 25-year-old woman with SLE was exposed to telitacicept during early pregnancy and delivered an infant without any physical defect. The patient was regularly receiving telitacicept injections. Her last dose was administered on 4 November 2024. Her last menstrual period was dated 7 November 2024, and telitacicept was discontinued upon pregnancy confirmation. During gestation, she was maintained on oral glucocorticoids, hydroxychloroquine, and tacrolimus. On 23 June 2025, at 32 weeks of gestation, she underwent a cesarean section due to \u201cintrauterine growth restriction and preeclampsia\u201d and delivered a male infant without any physical defects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case suggests that exposure to telitacicept in the early stage of pregnancy did not result in structural defects in this case.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1737355","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:43:20Z","timestamp":1768977800000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Telitacicept exposure in early pregnancy in a patient with SLE delivering an infant without any physical defect"],"prefix":"10.3389","volume":"12","author":[{"given":"Xiao-Shan","family":"Huang","sequence":"first","affiliation":[{"name":"State Key Laboratory of Traditional Chinese Medicine Syndrome, The First Clinical Medical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Department of Rheumatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong-yu","family":"He","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Traditional Chinese Medicine Syndrome, The First Clinical Medical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Department of Rheumatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-gang","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Traditional Chinese Medicine Syndrome, The First Clinical Medical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Department of Rheumatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Xu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Traditional Chinese Medicine Syndrome, The First Clinical Medical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Department of Rheumatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Guangdong Clinical Research Academy of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-song","family":"Lin","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Traditional Chinese Medicine Syndrome, The First Clinical Medical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Department of Rheumatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Guangdong Clinical Research Academy of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/ard-2022-223035","article-title":"Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study.","volume":"82","author":"Tian","year":"2023","journal-title":"Ann Rheum Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1016\/S0140-6736(24)00398-2","article-title":"Systemic lupus erythematosus.","volume":"403","author":"Hoi","year":"2024","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.ard.2025.02.023","article-title":"EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update.","volume":"84","author":"R\u00fcegg","year":"2025","journal-title":"Ann Rheum Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1456822","DOI":"10.3389\/fimmu.2024.1456822","article-title":"Telitacicept in combination with B-cell depletion therapy in MuSK antibody-positive myasthenia gravis: a case report and literature review.","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1177\/09612033241233021","article-title":"Refractory lupus hepatitis successfully treated with telitacicept who failed to belimumab: a case report and literature review.","volume":"33","author":"Fan","year":"2024","journal-title":"Lupus."},{"key":"B6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/s40001-023-01320-2","article-title":"Role of telitacicept in the treatment of IgA nephropathy.","volume":"28","author":"Wu","year":"2023","journal-title":"Eur J Med Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1298650","DOI":"10.3389\/fimmu.2023.1298650","article-title":"Combination treatment with telitacicept, cyclophosphamide and glucocorticoids for severe Granulomatous polyangiitis: a case report and literature review.","volume":"14","author":"Huang","year":"2023","journal-title":"Front Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1169084","DOI":"10.3389\/fimmu.2023.1169084","article-title":"Telitacicept for autoimmune nephropathy.","volume":"14","author":"Cai","year":"2023","journal-title":"Front Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1473190","DOI":"10.3389\/fimmu.2025.1473190","article-title":"Successful treatment of refractory systemic lupus erythematosus-associated immune thrombocytopenia with drug-induced liver injury with telitacicept: a case report and review.","volume":"16","author":"Li","year":"2025","journal-title":"Front Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.immuni.2012.11.015","article-title":"The BAFF receptor transduces survival signals by co-opting the B cell receptor signaling pathway.","volume":"38","author":"Schweighoffer","year":"2013","journal-title":"Immunity."},{"key":"B11","doi-asserted-by":"publisher","first-page":"241547","DOI":"10.1155\/2015\/241547","article-title":"Pregnancy associated with systemic lupus erythematosus: immune tolerance in pregnancy and its deficiency in systemic lupus erythematosus\u2013an immunological dilemma.","volume":"2015","author":"Gluhovschi","year":"2015","journal-title":"J Immunol Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"102864","DOI":"10.1016\/j.jaut.2022.102864","article-title":"Pregnancy-related complications in systemic lupus erythematosus.","volume":"132","author":"Tan","year":"2022","journal-title":"J Autoimmun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/sji.12453","article-title":"New insights into the management of patients with autoimmune diseases or inflammatory disorders during pregnancy.","volume":"84","author":"Tavakolpour","year":"2016","journal-title":"Scand J Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jaut.2018.07.016","article-title":"Safety issues and recommendations for successful pregnancy outcome in systemic lupus erythematosus.","volume":"93","author":"Nahal","year":"2018","journal-title":"J Autoimmun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00404-022-06718-7","article-title":"Pregnancy in patients with systemic lupus erythematosus: a systematic review.","volume":"308","author":"Zhang","year":"2023","journal-title":"Arch Gynecol Obstet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e70328","DOI":"10.1111\/1756-185X.70328","article-title":"Pregnancy outcomes in women with systemic lupus erythematosus (SLE): a matched-observational study from India.","volume":"28","author":"Mohan","year":"2025","journal-title":"Int J Rheum Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z","article-title":"Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies.","volume":"62","author":"Park-Wyllie","year":"2000","journal-title":"Teratology."},{"key":"B18","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0140-6736(01)06004-4","article-title":"Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases.","volume":"358","author":"Klinger","year":"2001","journal-title":"Lancet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.reprotox.2013.04.005","article-title":"Pregnancy outcome following in utero exposure to hydroxychloroquine: a prospective comparative observational study.","volume":"39","author":"Diav-Citrin","year":"2013","journal-title":"Reprod Toxicol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1136\/annrheumdis-2017-212535","article-title":"Effect of pregnancy on disease flares in patients with systemic lupus erythematosus.","volume":"77","author":"Eudy","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/art.42015","article-title":"Birth outcomes in women who have taken hydroxycholoroquine during pregnancy: a prospective cohort study.","volume":"74","author":"Chambers","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2810202","DOI":"10.1155\/2017\/2810202","article-title":"Hydroxychloroquine use in lupus patients during pregnancy is associated with longer pregnancy duration in preterm births.","volume":"2017","author":"Kroese","year":"2017","journal-title":"J Immunol Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/0002-9378(73)90559-0","article-title":"Immunosuppression during pregnancy: transmission of azathioprine and its metabolites from the mother to the fetus.","volume":"115","author":"Saarikoski","year":"1973","journal-title":"Am J Obstet Gynecol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s10067-015-2987-x","article-title":"Azathioprine during pregnancy in systemic lupus erythematosus patients is not associated with poor fetal outcome.","volume":"34","author":"Saavedra","year":"2015","journal-title":"Clin Rheumatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1002\/jcph.686","article-title":"Pharmacokinetics, pharmacodynamics, safety, and clinical activity of multiple doses of RCT-18 in Chinese patients with systemic lupus erythematosus.","volume":"56","author":"Zhao","year":"2016","journal-title":"J Clin Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"5811","DOI":"10.2147\/DDDT.S493923","article-title":"The latest progress in the application of telitacicept in autoimmune diseases.","volume":"18","author":"Liu","year":"2024","journal-title":"Drug Des Devel Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.placenta.2017.02.015","article-title":"Effect of glucocorticoids on mechanisms of placental angiogenesis.","volume":"52","author":"Ozmen","year":"2017","journal-title":"Placenta."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1737355\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:43:36Z","timestamp":1768977816000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1737355\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":27,"alternative-id":["10.3389\/fmed.2025.1737355"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1737355","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"article-number":"1737355"}}